Enterprise Financial Services Corp (EFSC)’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-23
Closed -$5K 936
2021
Q2
$5K Buy
23
+4
+21% +$778 ﹤0.01% 933
2021
Q1
$3K Buy
19
+15
+375% +$2.37K ﹤0.01% 1068
2020
Q4
$1K Buy
+4
New +$547 ﹤0.01% 1225

Other funds holding NVCR

Enterprise Financial Services Corp (EFSC)'s NVCR Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of NovoCure (NVCR) in Q3 2021, closing a stake of 23 shares — an estimated $5K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in NVCR in Q4 2020 and held it in 3 quarters. The position peaked at $5K in Q2 2021. 317 funds tracked by Wall St. Rank hold NVCR as of Q3 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining NovoCure position as of Q3 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 23 NovoCure shares in Q3 2021, an estimated $5K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in NovoCure in Q4 2020 and held it in 3 quarters.
  • Enterprise Financial Services Corp (EFSC)'s NovoCure position peaked at $5K in Q2 2021.
  • 317 funds tracked by Wall St. Rank held NovoCure as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.